Show
Sort by
-
Acute and late toxicity after postoperative high-dose pelvic radiotherapy and androgen deprivation for node positive prostate cancer patients: a powerful tool that should be handled with care?
-
Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcome
-
Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy